Medium aperture meso-caval shunts reliably prevent recurrent variceal hemorrhages

American Journal of Surgery

Volumn 171, Issue 5, 1996, Pages 490-494

  Scudamore, Charles H ^a,b   Erb, Siegfried R ^a   Morris, Chris ^a   Hemming, Alan ^a   Poostizadeh, Ahmad ^a   Buczkowski, Andrzej K ^a   Caron, Nadine ^a  

^a VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; ESOPHAGUS VARICES BLEEDING; FEMALE; HUMAN; LIVER BLOOD FLOW; LIVER TRANSPLANTATION; MALE; MORTALITY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0029980145     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)89610-9     Document Type: Article

References (32)

1. Blakemore AH, Lord JW. Technique of using vitellium tubes in establishing shunts for portal hypertension. Ann Surg. 1945;122: 476-489.
2. Marion P. Les obstructions portales. Semaine Hop. 1954;29: 2781-2789.
3. Valdoni P. Meine erfahrungen in der behandlung des portales uberdruckes. Helv Chir Acta. 1954;21:442-451.
4. Clatworthy HS, Wall T, Watman RN. A new type of portal to systemic venous shunt for portal hypertension. Arch Surg. 1955;71:588-596.
5. Nay HR, Fitzpatrick HF. A study of various types of superior mesenteric vein-inferior vena cava shunts via composite vein grafts. Surgery. 1966;59:540-546.
6. Stipa S, Thau A, Cavallaro, Rossi P.A technique for mesentericocaval shunt. Surg Gynecol Obs. 1973;137:285-287.
7. Read RC, Thompson BW, Wise WS, Murphy ML. Mesocaval H venous homografts. Arch Surg. 1970;101:785-789.
8. Lord JW, Jr, Rossi G, Daliana M, Rosati LM. Mesocaval shunt modified by the use of a teflon prosthesis. Surg Gyn Obs. 1970;130:595-596.
9. Giles GR, Brennan TG, Losowsky M.Interposition teflon mesenteric caval shunt for bleeding esophageal varices. Br J Surg. 1973;60:649-652.
10. Drapanas T. Interposition mesocaval shunt for treatment of portal hypertension. Ann Surg. 1972;176:435-448.
11. Rypins EB, Conroy RM, Sarfeh IJ. Advantages and disadvantages of polytetrafluoroethylene (PTFE) grafts for portacaval shunting. Vasc Surg. 1988;22:88-92.
12. Sarfeh IJ, Rypins EB, Mason GR. A systemic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg. 1986;207:356-363.
13. Sarfeh IJ, Rypins EB, Raiszadeh M, et al. Serial measurement of portal hemodynamics after partial portal decompression. Surgery 1986;100:52-57.
14. Sarfeh IJ, Rypins EB. Partial versus total portacaval shunt in alcoholic cirrhosis. Results of a prospective randomized clinical trial. Ann Surg. 1994;219:353-361.
15. Rypins EB, Milne N, Sarfeh IJ. Analysis of nutrient hepatic blood flow after 8 mm versus 16 mm portacaval H-grafts in a prospective randomized trial. Am J Surg. 1995;169:197-201.
16. Warren WD, Zeppa R, Foman JJ. Selective transplenic decompression of gastroesophageal varices by distal splenorenal shunt. Surgery. 1963;158:172-181.
17. Pugh RNH, Murray JM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60,646-649.
18. Bismuth H, Adam R, Mathur S, Sherlock D. Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. Am J Surg. 1990;160:105-110.
19. Cameron JL, Zuidema GD, Smith GW, et al. Mesocaval shunts for the control of bleeding esophageal varices. Surgery. 1979;85:257-262.
20. Rikkers LF, Jin G. Surgical management of acute variceal hemorrhage. World J Surg. 1994;18:193-199.
21. Isaksson B, Jeppsson B, Bengtsson F, et al. Mesocaval shunt or repeated sclerotherapy: effects on rebleeding and encephalopathy. A randomized trial. Surgery. 1995;117:498-504.
22. Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portasystemic shunts to control variceal bleeding before liver transplantation. Ann Intern Med. 1992;115:304-309.
23. Collins JC, Rypins EB, Sarfeh JJ. Narrow diameter portacaval shunts for management of variceal bleeding. World J Surg. 1994;18:211-215.
24. Henderson JM. Role of distal splenorenal shunt for longterm management of variceal bleeding. World J Surg. 1994;18:205-210.
25. Iwatsuki S, Starzl TE, Todo S, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery. 1988;104:697-705.
26. Ringe B, Laup H, Tusch G, Pichlmayr R. Role of liver transplantation in management of esophageal variceal hemorrhage. World J Surg 1994;18:233-239.
27. Paquet KJ, Mercada MA, Kalk JF, et al. Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension. Hepato Gastro. 1990;37:115-120.
28. Hederstrom E, Forsberg L, Ivancev K, et al. Ultrasonography and Doppler Duplex compared with angiography in follow-up of mesocaval shunt patency. Acto Radio. 1990;31:341-345.
29. Mazzaferro V, Todo S, Tzakis AG, et al. Liver transplantation in patients with previous portasystemic shunt. Am J Surg. 1990;160:111-115.
30. Drapanas T, Locicero J, Dowtrup JB. Hemodynamics of the interposition mesocaval shunt. Ann Surg. 1978;189:523-533.
31. Filtzer HS, Rossi R, Wolfort SG. Experience with interposition from mesocaval shunt for management of variceal bleeding. Arch Surg. 1977;112:593-601.
32. Reznick RK, Langer B, Taylor BR, et al. Results and hemodynamic changes after interposition mesocaval shunts. Surgery. 1984;95:275-280.